Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric Magnetic Resonance Imaging.

Sponsor
TC Erciyes University (Other)
Overall Status
Completed
CT.gov ID
NCT04944875
Collaborator
(none)
210
1
3
24
8.7

Study Details

Study Description

Brief Summary

To evaluate the effects of music and maternal voice in children on sedation depth and sedative use during pediatric magnetic resonance imaging.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Group headphone
  • Procedure: Group music
  • Procedure: Group maternal voice
N/A

Detailed Description

When the patients and their parents arrived in the magnetic resonance unıt about 30 minutes before the procedure, the anesthetist is obtained a medical history and carried out a physical examination and clinical assesment.

Patients were categorized into 3 groups: music, maternal voice and isolation. During the procedures,the patients in the music group listened to Vivaldi's The Four Seasons violin concertos by sound isolating headphones, whereas the patients in the isolation group wore the headphones but did not listen to music.

All patients were sedated by midazolam and propofol. During the procedure, an additional propofol was administered as required

Study Design

Study Type:
Interventional
Actual Enrollment :
210 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Diagnostic
Official Title:
Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric
Actual Study Start Date :
May 1, 2019
Actual Primary Completion Date :
May 1, 2021
Actual Study Completion Date :
May 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group I; group headphone

In the first group of the patients in the isolation group wear the headphones but do not listen to music during the procedure. Then patients were sedated by midazolam and propofol.

Procedure: Group headphone
The patients in the first group wore the headphones but did not listen the music or maternal voice. The standard sedation method was applied to all patients.

Active Comparator: Group II; group music

In the second group of the patients wear the headphones and listen to Vivaldi's The Four Seasons violin concertos by sound isolating headphones during the procedure. Then patients were sedated by midazolam and propofol.

Procedure: Group music
The patients in the second group listened to classical music (Vivaldi's The Four Seasons violin concertos) by sound- isolating headphones through the procedure.The standard sedation method was applied to all patients.

Active Comparator: Group III; group maternal voice

In the third group of the patients wear the headphones and listen the maternal voice during the procedure.Then patients were sedated by midazolam and propofol.

Procedure: Group maternal voice
The patients in the third group listened to maternal voice by sound- isolating headphones through the procedure.The standard sedation method was applied to all patients.

Outcome Measures

Primary Outcome Measures

  1. amount of propofol dose used in sedation [during the MRI procedure]

    The total propofol dosage were recorded in during procedure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASA (American Society of Anesthesiologists) I-II
Exclusion Criteria:
  • Patients with hearing impairment, distorted ear anatomy, recent organ or system deficiency, severe pulmonary and/or cardiovascular problems, intolerance to propofol, airway ab-normalities, or known psychiatric or mental problems were ex-cluded from the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Özlem Öz Gergin Kayseri Turkey 38090

Sponsors and Collaborators

  • TC Erciyes University

Investigators

  • Principal Investigator: Ozlem Oz Gergin, TC Erciyes University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Özlem ÖZ GERGİN, Principal Investigator, TC Erciyes University
ClinicalTrials.gov Identifier:
NCT04944875
Other Study ID Numbers:
  • 2019/266
First Posted:
Jun 30, 2021
Last Update Posted:
Jun 30, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Özlem ÖZ GERGİN, Principal Investigator, TC Erciyes University

Study Results

No Results Posted as of Jun 30, 2021